Found: 21
Select item for more details and to access through your institution.
Long-term clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: a meta-analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Epigenetic Targets and Their Inhibitors in Thyroid Cancer Treatment.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 4, p. 559, doi. 10.3390/ph16040559
- By:
- Publication type:
- Article
Predicting T-Cell Lymphoma in Children From <sup>18</sup>F-FDG PET-CT Imaging With Multiple Machine Learning Models.
- Published in:
- Journal of Digital Imaging, 2024, v. 37, n. 3, p. 952, doi. 10.1007/s10278-024-01007-y
- By:
- Publication type:
- Article
Second radioiodine treatment hardly benefits TT-DTC patients with radioiodine-negative metastases on initial post-therapeutic whole-body scans.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 67, n. 4, p. 294, doi. 10.23736/S1824-4785.23.03518-5
- By:
- Publication type:
- Article
AhR Antagonist Promotes Differentiation of Papillary Thyroid Cancer via Regulating circSH2B3/miR-4640-5P/IGF2BP2 Axis.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.795386
- By:
- Publication type:
- Article
Distinguishing Patients With Distant Metastatic Differentiated Thyroid Cancer Who Biochemically Benefit From Next Radioiodine Treatment.
- Published in:
- Frontiers in Endocrinology, 2020, v. 11, p. N.PAG, doi. 10.3389/fendo.2020.587315
- By:
- Publication type:
- Article
Targeting IGF2BP2 Promotes Differentiation of Radioiodine Refractory Papillary Thyroid Cancer via Destabilizing RUNX2 mRNA.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1268, doi. 10.3390/cancers14051268
- By:
- Publication type:
- Article
Combined tazemetostat and MAPKi enhances differentiation of papillary thyroid cancer cells harbouring BRAF<sup>V600E</sup> by synergistically decreasing global trimethylation of H3K27.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 6, p. 3336, doi. 10.1111/jcmm.15007
- By:
- Publication type:
- Article
Case report of <sup>18</sup>F-fluorodeoxyglucose positron emission tomography-computed tomography imaging of a patient with multiple endocrine gland metastases from small cell lung cancer.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 1, p. 167, doi. 10.1111/1759-7714.12523
- By:
- Publication type:
- Article
Unexplained Hyperthyroglobulinemia in Differentiated Thyroid Cancer Patients Indicates Radioiodine Adjuvant Therapy: A Prospective Multicenter Study.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.243642
- By:
- Publication type:
- Article
Unexplained Hyperthyroglobulinemia in Differentiated Thyroid Cancer Patients Indicates Radioiodine Adjuvant Therapy: A Prospective Multicenter Study.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.243642
- By:
- Publication type:
- Article
Unexplained Hyperthyroglobulinemia in Differentiated Thyroid Cancer Patients Indicates Radioiodine Adjuvant Therapy: A Prospective Multicenter Study.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.243642
- By:
- Publication type:
- Article
Unexplained Hyperthyroglobulinemia in Differentiated Thyroid Cancer Patients Indicates Radioiodine Adjuvant Therapy: A Prospective Multicenter Study.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.243642
- By:
- Publication type:
- Article
Unexplained Hyperthyroglobulinemia in Differentiated Thyroid Cancer Patients Indicates Radioiodine Adjuvant Therapy: A Prospective Multicenter Study.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.243642
- By:
- Publication type:
- Article
Unexplained Hyperthyroglobulinemia in Differentiated Thyroid Cancer Patients Indicates Radioiodine Adjuvant Therapy: A Prospective Multicenter Study.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.120.243642
- By:
- Publication type:
- Article
Unexplained Hyperthyroglobulinemia in Differentiated Thyroid Cancer Patients Indicates Radioiodine Adjuvant Therapy: A Prospective Multicenter Study.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.120.243642
- By:
- Publication type:
- Article
Discriminant function analysis of the occurrence risk of abnormal electrocardiogram in thyroidectomized differentiated thyroid carcinoma patients with short-term overt hypothyroidism.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Diagnosis and Treatment of Acute Pleural Effusion following Radioiodine Remnant Ablation Post Lobectomy for Thyroid Cancer.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 12, p. 2982, doi. 10.3390/diagnostics12122982
- By:
- Publication type:
- Article
ERBB2 as a prognostic biomarker correlates with immune infiltrates in papillary thyroid cancer.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.966365
- By:
- Publication type:
- Article
Random Forest for Predicting Treatment Response to Radioiodine and Thyrotropin Suppression Therapy in Patients With Differentiated Thyroid Cancer But Without Structural Disease.
- Published in:
- Oncologist, 2024, v. 29, n. 1, p. e68, doi. 10.1093/oncolo/oyad252
- By:
- Publication type:
- Article
Clinicopathological Features Predict Outcomes in Patients with Radioiodine‐Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Real‐World Study.
- Published in:
- Oncologist, 2020, v. 25, n. 4, p. e668, doi. 10.1634/theoncologist.2019-0633
- By:
- Publication type:
- Article